Instil Bio Stock
Instil Bio, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Bronson Crouch
- Employees
- 17
- Market cap
- $40 M
- IPO
- 19/03/2021
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas,…
Instil Bio stock: price history
1D
-3.6%
1W
-12.3%
1M
-17.7%
6M
-33.4%
YTD
-46.3%
1Y
-70.7%
2Y
-85.6%
5Y
-98.4%
10Y
–
Next earnings date
Next earnings date
16/11/2026 (in 30 days)
Volatility around earnings
~28% weaker price swings than usual
Ask the agents about Instil Bio
Analyst assessment of Instil Bio
PRICE TARGET LOW
US$2.00
CONSENSUS
US$35.00
MEDIAN
US$9.00
PRICE TARGET HIGH
US$120.00
0
STRONG BUY
2
BUY
6
HOLD
0
SELL
0
STRONG SELL
8
TOTAL · Hold
As of: 07/01/2026
Instil Bio stock metrics
P/E
-1.32
P/B
0.37
EV/EBITDA
-1.29
RETURN ON EQUITY
-4.0%
NET MARGIN
0.0%
DEBT/EQUITY
0.03
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
54.0%
FLOAT SHARES
3,661,453
AVG. DAILY VOLUME (30D)
20,286
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Instil Bio stock
What does Instil Bio do?
Instil Bio, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Bronson Crouch, the company employs around 17 people.
The IPO was on 19/03/2021; the stock trades on NASDAQ under the ticker TIL.
What do analysts say about Instil Bio stock?
8 analysts rate the stock, the consensus is Hold (as of 07/01/2026).
The average price target is US$35.00, ranging from US$2.00 to US$120.00, with a median of US$9.00.
This is an external assessment, not a statement by Market Jury.
When does Instil Bio report next?
The next earnings date is 16/11/2026.
Around past earnings, price swings were roughly -28% stronger than usual.
Does Instil Bio pay a dividend?
No, Instil Bio currently does not pay a dividend.
Which stocks are comparable to Instil Bio?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Instil Bio stock analyzed?
Clicking "Analyze stock" lets five strategies assess Instil Bio against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.